Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

University of Alberta

$20,000.00

Workshop to CAPTURE ALS

EF 2018-19

Résumé
Amyotrophic Lateral Sclerosis (ALS) is the most common adult-onset motor neuron disease, characterized by a degeneration of the brain and spinal cord leading to progressive muscular weakness. Despite an increasing understanding of the complex biology of ALS, an important barrier to development of effective tests and treatments is the lack of sensitive and objective human biomarkers. To address this issue, the Canadian ALS Neuroimaging Consortium (CALSNIC) was established. CALSNIC is a multidisciplinary group of scientists funded by CIHR, ALS Canada and Brain Canada. It provides a platform for clinical and translational studies on a national scale. Its strength is the ability to collect disease information over multiple clinical visits, with clinical, cognitive and MRI metrics in a standardized fashion across 7 sites. We propose to create the Comprehensive Analysis Platform To Understand, Remedy and Eliminate (CAPTURE) ALS initiative, which builds on the CALSNIC clinical and imaging program by adding pan-Canadian procurement of biological samples. This will form a national biorepository network that facilitates rapid sharing of invaluable data and samples with Canadian and international scientists, and contribute to large discovery projects aimed at understanding ALS further. CAPTURE ALS will drive more impactful research, accelerate our understanding of the heterogeneity of ALS, accelerate highly needed biomarker discoveries and lead to novel treatments for ALS. Most importantly, it will reinforce Canada's standing as an international leader in ALS research. As a necessary step to establishing CAPTURE ALS, we propose to hold a 1-day workshop in Montreal to bring together the various ALS research and clinical groups in Canada to establish the foundation for a pan-Canadian ALS research network with harmonized tools (consent forms, SOPs, protocols, etc.) and shared resources (biosamples, datasets, etc.).
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
404447
Name
Kalra Sanjay
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Planning and Dissemination - INMHA
Projecttitle
Workshop to CAPTURE ALS
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Alberta
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Amyotrophic Lateral Sclerosis; Workshop
Abstract
Amyotrophic Lateral Sclerosis (ALS) is the most common adult-onset motor neuron disease, characterized by a degeneration of the brain and spinal cord leading to progressive muscular weakness. Despite an increasing understanding of the complex biology of ALS, an important barrier to development of effective tests and treatments is the lack of sensitive and objective human biomarkers. To address this issue, the Canadian ALS Neuroimaging Consortium (CALSNIC) was established. CALSNIC is a multidisciplinary group of scientists funded by CIHR, ALS Canada and Brain Canada. It provides a platform for clinical and translational studies on a national scale. Its strength is the ability to collect disease information over multiple clinical visits, with clinical, cognitive and MRI metrics in a standardized fashion across 7 sites. We propose to create the Comprehensive Analysis Platform To Understand, Remedy and Eliminate (CAPTURE) ALS initiative, which builds on the CALSNIC clinical and imaging program by adding pan-Canadian procurement of biological samples. This will form a national biorepository network that facilitates rapid sharing of invaluable data and samples with Canadian and international scientists, and contribute to large discovery projects aimed at understanding ALS further. CAPTURE ALS will drive more impactful research, accelerate our understanding of the heterogeneity of ALS, accelerate highly needed biomarker discoveries and lead to novel treatments for ALS. Most importantly, it will reinforce Canada's standing as an international leader in ALS research. As a necessary step to establishing CAPTURE ALS, we propose to hold a 1-day workshop in Montreal to bring together the various ALS research and clinical groups in Canada to establish the foundation for a pan-Canadian ALS research network with harmonized tools (consent forms, SOPs, protocols, etc.) and shared resources (biosamples, datasets, etc.).
Competitiondate
201903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kalra, Sanjay
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $20,000~ $0~